Literature DB >> 862179

A rapid micromethod for measuring theophylline in serum by reverse-phase high-performance liquid chromatography.

S J Soldin, J G Hill.   

Abstract

We describe an assay system for measuring theophylline in 25 microliters of serum. The procedure involves extraction with a 95:5 mixture of chloroform:isopropanol containing beta-hydroxypropyltheophylline as internal standard, and reverse-phase chromatography on a 4 mm x 30 cm column containing "micron Bondapak C18." Theophylline and beta-hydroxypropyltheophylline are eluted with a 90:10 mixture of sodium acetate butter (20 mmoles/litre pH 4.0) and acetonitrile at a flow rate of 1.8 ml/min., are detected by their absorbance at 254 nm, and quantitated by measuring peak areas. Column temperature has not been found to be critical in this analysis. Each analysis requires 9 minutes of chromatography time with a total analysis time of 20 minutes. Analytical recoveries were found to be 71 to 75% for theophylline and 94% for beta-hydroxypropyltheophylline. This difference in recovery is corrected when determining the theophylline concentration in unknown samples. The method has good precision (coefficients of variation between 7.0% and 7.9% for therapeutic and toxic concentrations). The results obtained with this method compare favourably with results obtained by a published cation-exchange high-performance liquid chromatographic method. None of the metabolites of theophylline, common compounds related to theophylline in structure or drugs tested have been found to interfere with the analysis described.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 862179     DOI: 10.1016/s0009-9120(77)90928-6

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  7 in total

Review 1.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

Review 2.  Drug interferences with plasma assays in therapeutic drug monitoring.

Authors:  S Yosselson-Superstine
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

3.  Endogenous adenosine inhibits lipolysis induced by nerve stimulation without inhibiting noradrenaline release in canine subcutaneous adipose tissue in vivo.

Authors:  A Sollevi; P Hjemdahl; B B Fredholm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-04       Impact factor: 3.000

Review 4.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

5.  Additive renal effects of indomethacin and dipyridamole in man.

Authors:  P Seideman; A Sollevi; B B Fredholm
Journal:  Br J Clin Pharmacol       Date:  1987-03       Impact factor: 4.335

6.  Determinants of the plasma protein binding of theophylline in health.

Authors:  D Buss; D Leopold; A P Smith; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

7.  The osteogenic effect of liraglutide involves enhanced mitochondrial biogenesis in osteoblasts.

Authors:  Subhashis Pal; Shailendra K Maurya; Sourav Chattopadhyay; Shyamsundar Pal China; Konica Porwal; Chirag Kulkarni; Sabyasachi Sanyal; Rohit A Sinha; Naibedya Chattopadhyay
Journal:  Biochem Pharmacol       Date:  2019-03-15       Impact factor: 5.858

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.